Yuya Hashimura

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Hiromichi Hamada, Hiroyuki Suzuki, Yoshihiro Onouchi et al. · The Lancet · 2019 · 202 citations

Cardiovascular Disease, Atherosclerosis, Intravenous Immunoglobulin +7

Validity of the Oxford classification of IgA nephropathy in children

Yuko Shima, Koichi Nakanishi, Taketsugu Hama et al. · Pediatric Nephrology · 2011 · 110 citations

Glomerular Disease, Glomerulonephritis, Medicine +8

Natural history of genetically proven autosomal recessive Alport syndrome

Masafumi Oka, Kandai Nozu, Hiroshi Kaito et al. · Pediatric Nephrology · 2014 · 88 citations

Mendelian Disorder, Genetic Disorder, Genetics +5

Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain

Yuya Hashimura, Kandai Nozu, Hiroshi Kaito et al. · Kidney International · 2013 · 88 citations

X-linked Alport Syndrome, Pathology, Milder Clinical Aspects +4

Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome

Yuya Hashimura, Kandai Nozu, Hirokazu Kanegane et al. · Pediatric Nephrology · 2009 · 87 citations

Glomerular Disease, Glomerulonephritis, Autoimmune Disease +13